CorporateInformation.com
 
Company Search:
Advanced Search
 
Featured Products and Services
 
 
Wright Investors Service Perspectives
 
 
 
     
  The Wright Reports site is no longer hosted or operated by Manta. Please review the following:
1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing.
2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com
3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp
4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later) 		 
     
 
 
 
Jiangsu Hengrui Medicine Co., Ltd. Company Snapshot
Business Description:
Jiangsu Hengrui Medicine Co., Ltd. operates in the Medicinals and botanicals sector. Jiangsu Hengrui Medicine Co., Ltd. is principally engaged in the manufacturing and distribution of pharmaceutical tablets, injections and raw materials. The Company is also involved in medicine commerce. The Company mainly provides antineoplastic drugs, drugs for the treatment of cardiovascular disease, drugs for surgery, drugs for the treatment of endocrine, antibiotics, big infusions and others, including calcium levofolinate for injection, cyclophosphamide for injection, etoposide for soft capsules, calcium folinate tablets, irbesartan tablets, bupivacaine hydrochloride for injection, levofloxacin hydrochloride tablets, glucose injections and sodium chloride injections, among others. The Company distributes its products primarily in domestic market. In our complete report available for purchase the company is compared to: Tianjin Zhong Xin Pharmaceutical Group Corporation Limited, Zhejiang NHU Co.,Ltd and Guangdong Kangmei Pharmaceutical Co..
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Jiangsu Hengrui Medicine Co., Ltd.
  Stock Performance Chart for Jiangsu Hengrui Medicine Co., Ltd.
 
  Stock Data: Recent Stock Performance:
  Current Price (2/3/2012): 26.39
(Figures in Chinese Renmimbi)
1 Week n/a   13 Weeks -0.6%  
4 Weeks -13.6%   52 Weeks -19.9%  
 
Jiangsu Hengrui Medicine Co., Ltd. Key Data:
  Ticker: 600276 Country: CHINA
  Exchanges: SHG Major Industry: Drugs, Cosmetics & Health Care
    Sub Industry: Ethical Drug Manufacturers
  2010 Sales 3,744,106,000
(Year Ending Jan 2011).		 Employees: 4,569
  Currency: Chinese Renmimbi Market Cap: 29,666,311,797
  Fiscal Yr Ends: December Shares Outstanding: 1,124,149,746
  Share Type: A Gu Closely Held Shares: 531,205,438
 
 
Featured Products and Services
  
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.